Nocebo Effect Explained: Here's How Placebo Effect's Negative Counterpart Works

Medicine & Technology May 01, 2024

The nocebo effect refers to when a person's negative expectations towards treatment could lead to negative side effects. Read to learn more.

Food Intake and Dementia Risk Link Discovered in Epidemiological Studies and Clinical Trials

Jul 05, 2022

Researchers investigate the link between diet and the risk of developing dementia. How does technology play part in finding the link? Read to know more about it.

IMV Released Final Topline Results for Its DeCidE1 Clinical Trial

Sep 05, 2021

Biopharmaceutical firm IMV has released the final topline results for its DeCidE1 Phase 2 clinical trial.

New COVID-19 Vaccine on Phase 3 Trials: Sanofi, GSK Announce Involvement of 35,000 Participants

May 28, 2021

European drug manufacturers Sanofi and GlaxoSmithKline or GSK announced yesterday that they are launching large-scale clinical trials for their new COVID-19 vaccines.

Two COVID-19 Vaccines Found Less Effective in South Africa Strain

Jan 31, 2021

Latest reports show two COVID-19 vaccines are less efficient in South Africa than in other nations they were tested on.

COVID-19 Vaccine: Should People With an Autoimmune Disease Get a Shot?

Jan 13, 2021

Many people who decide to get a vaccine as protection from COVID-19 can now back their decision with data containing clinical trial, which has demonstrated vaccines' safety and effectiveness.

Immunologist Claire Bryant Carefully Assess the Pfizer Vaccine

Nov 18, 2020

Cambridge immunologist Claire Bryant joins BBC's The Naked Scientist podcast to discuss the Pfizer and BioNTech vaccine candidate. Bryant answers key questions about the vaccine technology, side effects, and probable availability.

Progress in Light Therapy Research May Pave Way for Treating Brain Injuries

Sep 23, 2020

Traumatic brain injury is one of the major head injuries seen around the world with limited available therapy. Researchers look into light therapy, which may someday be effective in treating other forms of brain injuries.

China’s Biotech Firm Is Now Leading the Race to a Coronavirus Vaccine As Testing Approaches Phase 3

Jul 02, 2020

CanSino was the first biotech firm to complete successful human trials with a COVID-19 vaccine. They've continued to take the lead as they will soon begin Phase 3 with consistent promising efforts.

Studies That Most Likely Led WHO to Halt Hydroxychloroquine Covid-19 Trials Are Under Fire Amid Questionable Data From Surgisphere

Jun 03, 2020

Some studies published under clinical journals are under fire after it was revealed that the data used in their papers were deemed questionable. The said data were provided by a company called Surgisphere, which has yet to release a statement about the issue. Click the link above to learn more.

WHO Stops Hydroxychloroquine Coronavirus Trials Over Safety Concerns

May 25, 2020

The World Health Organization is temporarily putting a hold on clinical trials for the antimalarial drug, hydroxychloroquine. This decision was after studies showed that the drug potentially caused heart problems and even death. Click the link above to learn more.

Clinical Analysis Reveals drug Slows down Respiratory Decline

Jul 10, 2019

The research demonstrates that eteplirsen may slow the rate of respiratory decline and therefore may delay time to milestones of decline

Pancreatic Cancer Setting Clinical Trials Aiming The Right & Individualized Treatment

Mar 27, 2017

A network of clinical trials was set for the development of new treatments for pancreatic cancer, after a £10 million investment from Cancer Research UK.

Pfizer Announces IBRANCE Clinical Trials Ended Early In Light of Promising News

Apr 16, 2015

In light of promising results conducted by an independent data monitoring committee, Pfizer’s newest treatment IBRANCE (Palbociclib) ended clinical trials early this week as phase 3 of the trials ended demonstrating improvement in progression-free survival in women who had undergone treatment for metastatic breast cancer.

Experimental ZMapp Treatment Off To Liberia to Begin Clinical Trials

Jan 24, 2015

The experimental ZMapp treatment created by Mapp Biopharmaceutical will soon begin human clinical tries in the United States and Liberia, following efforts to boost production capacity.